Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03353246
Other study ID # Pro00087011
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 11, 2017
Est. completion date May 4, 2018

Study information

Verified date April 2019
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScanner 2000™, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Duke University Hospital (DUH) who have sustained or who are suspected to have sustained head trauma and have consequently received a brain computed tomography (CT) scan(s).


Description:

When applicable (conscious patient and/or family or legally authorized representative is present) the study will be introduced to the patient and relevant parties prior to the research team approaching the patient. While head trauma frequently results in impaired cognition and/or consciousness, and due to the urgency of these circumstances patients are often not accompanied by kin, whenever appropriate, the purpose of the research and the procedure will be explained in detail with all questions answered to the patient's and/or representative's satisfaction. Because patients who sustain head trauma injuries typically remain within the hospital for multiple days for monitoring and care, each participant may undergo multiple CT scans over the course of his or her hospitalization, affording the opportunity to one to numerous measurements from each patient during his or her hospital stay.

Within 30 minutes following each CT scan, the study team will approach the patient to scan the patient's cranium with the InfraScanner 2000™ (Image A). The procedure will entail placing 8 plastic light guides upon the patient's scalp. The study team member will use the device to sequentially emit light through each of the 8 light guides so that the light is incident upon scalp (Image B). The device is engineered such that the light emitter and receiver are spaced ~4cm apart, allowing the light's intensity to be measured between adjacent light guides (Image C). This entire procedure, including greeting the patient, placing the light guides, gathering the data, and removing the light guides should take ~10 minutes each time. The number of CT scans the patient receives determines the number of potential data collections. The patient will be approached by the study team following each CT scan to be scanned with the InfraScanner 2000™ (20). The patient and/or representative may refuse a scan during any encounter, and as such, the scan will not be done. For each patient scanned with the InfraScanner 2000™ they will be de-identified with a subject number, with age, sex, gender, skin color, hair color, hair thickness, mechanism of injury, Glasgow Coma Scale score, and mean time elapsed between CT scan and near-infrared measurement. These data will be stored in de-identified form on Research Electronic Data Capture (REDCap) and/or Microsoft Excel 2016 on a secured DHTS server (S:\NSU_IRB\Pro00087011).

The collection period for each research subject concludes 30-days following his or her initial measurement with the InfraScanner 2000™, patient discharge, or patient death.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date May 4, 2018
Est. primary completion date May 4, 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Any patient who presents to Duke University Hospital with suspected head trauma and receives a brain CT scan will be considered for this study.

Exclusion Criteria:

- None

Study Design


Related Conditions & MeSH terms

  • Craniocerebral Injuries
  • Craniocerebral Trauma
  • Crushing Skull Injury
  • Head Injuries
  • Head Injuries, Closed
  • Head Injuries, Multiple
  • Head Injuries, Penetrating
  • Head Injury Major
  • Head Injury, Minor
  • Head Injury, Open
  • Head Trauma
  • Head Trauma Injury
  • Head Trauma, Penetrating
  • Head Trauma,Closed
  • Hematoma
  • Injuries, Craniocerebral
  • Injuries, Head
  • Multiple Head Injury
  • Multiple Trauma
  • Trauma, Head
  • Wounds and Injuries

Intervention

Device:
InfraScanner 2000™
The Infrascanner is a portable screening device that uses Near-Infrared (NIR) technology to screen patients for intracranial bleeding, identifying those who would most benefit from immediate referral to a CT scan and neurosurgical intervention.

Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity of InfraScanner 2000 TM to Detect Any Size Hematoma at the Patient Level Percentage of subjects with hematomas detected by CT who had hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary Sensitivity of InfraScanner 2000 TM to Detect Any Size Hematoma at the Scan Level Percentage of CT scans with hematomas detected that had hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary Specificity of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Patient Level Percentage of patients with no hematomas detected by CT who had no hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary Specificity of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Scan Level Percentage of CT scans with no hematomas detected that had no hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary False Positive Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Patient Level Percentage of patients with no hematomas detected by CT that had hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary False Positive Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Scan Level Percentage of scans with no hematomas detected by CT that had hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary False Negative Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Patient Level Percentage of patients with hematomas detected by CT that had no hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Primary False Negative Rate of InfraScanner 2000 TM for Detection of Any Size Hematoma at the Scan Level Percentage of scans with hematomas detected by CT that had no hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Secondary Sensitivity in Identification of Hematomas Within Detection Limits, at the Patient Level Percentage of subjects with hematomas within detection limits detected by CT who had hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Secondary Specificity in Identification of Hematomas Within Detection Limits, at the Patient Level Percentage of patients with no hematomas within detection limits detected by CT who had no hematoma detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Secondary Sensitivity for Bleeds Within Detection Limits by Hematoma Type at the Patient Level Percentage of subjects with hematomas within detection limits detected by CT that were detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Secondary False Negative Value for Bleeds Within Detection Limits by Hematoma Type at the Patient Level Percentage of subjects with hematomas within detection limits detected by CT where no hematoma was detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Secondary Sensitivity for Bleeds Within Detection Limits by Hematoma Type at the Scan Level Percentage of CT scans with hematomas within detection limits detected by CT that were detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
Secondary False Negative Value for Bleeds Within Detection Limits by Hematoma Type at the Scan Level Percentage of CT scans with hematomas within detection limits detected by CT where no hematoma was detected by Infrascanner 2000 TM. Up to 30 days after first CT scan
See also
  Status Clinical Trial Phase
Completed NCT03291964 - Rapid MRI for Acute Pediatric Head Trauma
Completed NCT02828306 - Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects
Completed NCT04505293 - Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas N/A
Not yet recruiting NCT02232347 - Ketamine and Glutamate After Brain Injury : a Microdialysis Study Phase 2
Completed NCT01448473 - Is a Two-Film Skull X-ray Series as Sensitive as a Four-Film Series in the Diagnosis of Skull Fractures in Paediatric Patients N/A
Terminated NCT00847977 - Interest of Using Balanced Fluid for Infusion at the Early Phase of an Acute Cranial Trauma for Limiting Hyperchloremic Acidosis Phase 3
Completed NCT00622778 - Immunemodulation in Patients With Minor Head Injury N/A
Completed NCT04495634 - Evaluation of a Carbon Nanotube Enabled Solid-State Head CT N/A
Terminated NCT03680911 - NAC for Head Trauma-induced Anosmia Phase 3
Recruiting NCT06173427 - Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD
Completed NCT03742427 - Effect of Cervical Collar on the Optic Nerve Sheath Diameter in Minor Head Trauma N/A
Terminated NCT06246500 - Severe Head Trauma: Coagulation and CT-Scan Aggravation.
Withdrawn NCT03453749 - Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury Phase 2
Completed NCT00995683 - Preventive Sodium Lactate and Traumatic Brain Injury Phase 2/Phase 3
Not yet recruiting NCT05195606 - The Effect of Auditory and Tactile Stimuli in Traumatic Coma N/A
Completed NCT04020874 - Reducing Head Impact Exposure in Hawaii High School Football N/A
Not yet recruiting NCT06113939 - Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning N/A
Recruiting NCT05386966 - Medicolegal Aspects of Head Trauma
Not yet recruiting NCT03704272 - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral N/A
Active, not recruiting NCT00196131 - Problems With Morphine Use in Patients With a Severe Brain Injury Phase 1/Phase 2